6 TECH OUTLOOKFebruary 2017Copyright © 2017 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.FEBRUARY - 2017Editor-in-ChiefStacey SmithEditorial StaffSalesAaron PierceAlex D'Souza Eileen SinghJem Elizabeth Joshua ParkerSarah FernandesVisualizerStephen ThomasArpita GhoshEnterprise Software SpecialBrian Thomas brian@pharmatechoutlook.comEditorialStacey Smith Editor-in-ChiefThe pharmaceutical industry has been facing unprecedented challenges, over the past few years. Even though hubs of innovation and advanced solutions have been widely shaping business processes, pharma companies are struggling to bring new drugs to market due to pricing pressures caused by healthcare reforms and increased competition.However, with the emergence of enterprise software and solutions, "big pharma" is creating new growth opportunities which will have a fundamental impact on the future success of drug development. Breaking the traditional approach, advancements in genomic technologies and data science methodologies have made it possible for modern pharmaceuticals to get close to achieving the goal of personalized medicine. In the meantime, automation and robotics-based strategies are also gaining momentum in phrama manufacturing as a part of its technology-enabled transformation that comprises 3-D biological printing, ultra-high-resolution analytical instruments, next-generation sequencing, and desktop electron microscopy. From drug discovery to pharmaceutical and medical device manufacturing, to performing blood sample testing, robotics is bringing immense capability to gain an impressive throughput at a faster rate. As demands for safe and efficacious pharmaceutical drugs grow, pharma companies are gaining a better understanding of diseases, broadening R&D strategies, and getting a better focus on treatments. This calls for advanced analytics tools and machine learning to derive high-value information and generate data insights produced from experimental or manufacturing processes. At this stage, along with the better quality data, it is critical to implement enterprise software solutions, driven by new technologies and tools, to revolutionize pharmaceutical manufacturing and drug development--ultimately resulting in operational efficiency. With this mind, in this edition of Pharma Tech Outlook, we bring to you the Top 10 Enterprise Software Solution Providers. We hope this information will help you redefine your pharmaceutical manufacturing and improve speed, performance, cost, and results of your research efforts.Taking a Modernized Approach TECH OUTLOOKMailing AddressValleyMedia Inc.44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510 230 0396, F:510-894-8405 February - 2017, volume 03 - 02 Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com TECH OUTLOOK
< Page 5 | Page 7 >